Document is current
Any future updates will be listed below
-
Authors
Patel, Ronak
Marrie, Ruth Ann
Bernstein, Charles N.
Bolton, James M.
Graff, Lesley A.
Marriott, James J.
Figley, Chase R.
Kornelsen, Jennifer
Mazerolle, Erin L.
Uddin, Md Nasir
Fisk, John D.
,
Bolton, James
Graff, Lesley
Kornelsen, Jennifer
Mazerolle, Erin
Patel, Ronak
Figley, Teresa D.
Helmick, Carl A.
-
Funding
Funding for this research was provided by:
Waugh Family Foundation MS Society of Canada Operating Grant (EGID 2639, EGID 2639, EGID 2639)
Canadian Institutes of Health Research (THC-135234, THC-135234, THC-135234)
Crohn’s and Colitis Canada
Waugh Family Chair in Multiple Sclerosis
Bingham Chair in Gastroenterology
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 7 March 2023
First Online: 15 March 2023
Competing interests
: Dr. Bernstein is supported in part by the Bingham Chair in Gastroenterology. Dr. Bernstein has consulted to Abbvie Canada, Amgen Canada, Bristol Myers Squibb Canada, Janssen Canada, Pfizer Canada, Roche Canada, Sandoz Canada, Takeda Canada, and has received unrestricted educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, and Takeda Canada. He has consulted to Takeda and Mylan Pharmaceuticals. He has been on the speaker’s bureau of Abbvie Canada, Janssen Canada, Medtronic Canada and Takeda Canada. He has received a research grant from Abbvie Canada and contract grants from Abbvie, Janssen, Pfizer, Roche, Boeringher Ingelheim. Dr Graff has consulted to Roche Canada. All other authors do not possess any competing interest.
